当前位置: X-MOL 学术Int. J. Neuropsychopharmacol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
LIMK1/2 in the mPFC plays a role in chronic stress-induced depressive-like effects in mice.
International Journal of Neuropsychopharmacology ( IF 4.8 ) Pub Date : 2020-08-22 , DOI: 10.1093/ijnp/pyaa067
Ting-Ting Gao 1, 2 , Yuan Wang 1, 2 , Ling Liu 1, 2 , Jin-Liang Wang 1, 2 , Ying-Jie Wang 1, 2 , Wei Guan 1, 2 , Ting-Ting Chen 1, 2 , Jie Zhao 3 , Bo Jiang 1, 2
Affiliation  

Depression is one of the most common forms of mental illness and also a leading cause of disability worldwide. Developing novel antidepressant targets beyond the monoaminergic systems is now popular and necessary. LIM kinases, including LIM domain kinase 1 and 2 (LIMK1/2), play a key role in actin and microtubule dynamics through phosphorylating cofilin. Since depression is associated with atrophy of neurons and reduced connectivity, here we speculate that LIMK1/2 may play a role in the pathogenesis of depression.

中文翻译:

mPFC 中的 LIMK1/2 在小鼠慢性应激诱导的抑郁样效应中起作用。

抑郁症是最常见的精神疾病形式之一,也是世界范围内导致残疾的主要原因。开发单胺能系统以外的新型抗抑郁药靶点现在很流行也很有必要。LIM 激酶,包括 LIM 域激酶 1 和 2 (LIMK1/2),通过磷酸化 cofilin 在肌动蛋白和微管动力学中发挥关键作用。由于抑郁症与神经元萎缩和连接性降低有关,因此我们推测 LIMK1/2 可能在抑郁症的发病机制中发挥作用。
更新日期:2020-08-22
down
wechat
bug